'Immediately open access' option for the leading journal Genome Research

ortant reason that the "immediately open access" option is possible for Genome Research and the surcharge has been set at a level that anticipates the continuation of multiple revenue streams. "We recognize that if a large proportion of authors choose immediately open access, librarians may come to feel it is not worth continuing to subscribe to Genome Research" Inglis said. "We plan to engage the library community in a dialogue as our experience with this option grows, to make sure the journal's ability to contribute to the advance of science isn't undermined."

Dr. Hillary Sussman, Managing Editor of Genome Research added, "It is clear that some scientists, many of them active in the genome science community, are personally committed to the philosophy of open access and have the resources to support the 'author-pays' model of publication charges. By making the immediately open accessoption available, Genome Research is providing those scientists with the opportunity to publish in an established, high-profile journal, while continuing to offer timely public access to the cutting-edge genomic science contributed by all our authors."

Genome Research is an international, monthly, peer-reviewed research journal publishing genome studies and genome-based analysis of biological processes in all species. Launched in 1995, it has an impact factor of 9.635, placing it among the Institute for Scientific Information's (ISI) five most highly cited primary research journals in genetics. New data in genetics, comparative and functional genomics, proteomics, evolution studies, systems biology, bioinformatics, epigenetics, and technology are published as research papers in the form of articles and letters, or methods and resource reports. Complete data sets are presented electronically on the journal's web site where appropriate. The journal also provides review articles, perspectives, and Insight/Outlook articles that comment on the latest advances published in th

Contact: Elizabeth Powers
Cold Spring Harbor Laboratory

Page: 1 2 3

Related biology news :

1. Real-time Plant Physiology: ASPB extends open access benefit for members
2. Senior academic officers oppose public access legislation
3. Macrochem acquires option to license pexiganan
4. European approval of HIV drug darunavir will provide a potent new option with Fuzeon
5. Fat stem cells being studied as option for breast reconstruction
6. Drug offers new options for leukemia patients
7. Breast-sparing surgery an option for women with breast cancer gene mutation, U-M-led study finds
8. New treatment option breaks Leukemias resistance to chemotherapy, radiation therapy
9. Avian flu modeled on supercomputer, explores vaccine and isolation options for thwarting a pandemic
10. STN AnaVist 1.1 offers new options for sharing
11. Accentia Biopharmaceuticals announces option agreement with Mayo

Post Your Comments:

(Date:1/29/2020)... ... 29, 2020 , ... INDIGO Biosciences, Inc. (INDIGO), the recognized ... a record earnings year for 2019. With final numbers to be released to ... increase in revenue and a thirty percent increase in gross profit, and more ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cytonus ... a noted investor, tech entrepreneur, and former senior management consultant at McKinsey & ... Capital, the global alternative investment firm. , “Chris Thorne has exceptional business ...
(Date:1/23/2020)... ... January 23, 2020 , ... GIOSTAR/HEAMGEN has ... stem cells. The red blood cells are made utilizing a bioreactor that ... transfusion therapy and replaces the need for a human blood donor. ...
Breaking Biology News(10 mins):
(Date:2/13/2020)... ... February 12, 2020 , ... Arriello ... services, is adopting Veeva Vault Safety™ as part of the company’s ... assessment of data, processing of safety information such as SUSARs and ICSRS, aggregate ...
(Date:2/5/2020)... ... February 05, 2020 , ... Rare Disease Day® ... by The National Organization for Rare Disorders (NORD), to raise awareness amongst the general ... ). The Balancing Act’s “Behind The Mystery” rare disease series will be ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... Assay Kits . The new Salivary Total Human IgG Assay Kit ... immunoglobulin G in saliva, researchers can extend the accuracy and ease of use ...
(Date:1/24/2020)... Calif. (PRWEB) , ... January 24, 2020 , ... ... launch of their RedySmart™ mass flow meters and controllers ideal for ... as an ideal upgrade to antiquated rotameters. These thermal instruments employ high-precision MEMS ...
Breaking Biology Technology:
Cached News: